Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1002/pd.1970151205 http://scihub22266oqcxt.onion/10.1002/pd.1970151205 8750289!?!8750289 Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=8750289&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Prenat+Diagn 1995 ; 15 (12): 1109-13 Nephropedia Template TP {{tp|p=8750289|t=1995. Prevalence and clinical significance of anticardiolipin antibodies in pregnancies complicated by parvovirus B19 infection |pdf=|usr=}}{{8750289}} gab.com Text Prevalence and clinical significance of anticardiolipin antibodies in pregnancies complicated by parvovirus B19 infection JO: Prenat Diagn http://www.kidney.de/pget.php?&tw=1&pmid=8750289 #FOAvip Anticardiolipin antibodies were measured in 60 pregnant women with acute parvovirus B19 infection. Test results for eight (13.3 per cent) women were positive for anticardiolipin antibody. Six of these eight women became negative later, yielding a prevalence of anticardiolipin antibodies of 3.3 per cent (2/60) 6 months after acute parvovirus B19 infection. Anticardiolipin antibody positivity was not associated with an increased risk of abortion, fetal death, or maternal complications. This study suggests that there is an elevated frequency of anticardiolipin antibodies in pregnant women with acute parvovirus B19, probably representing an epiphenomenon. However, this is not associated with an adverse maternal or perinatal outcome. Twit Text FOAVip Prevalence and clinical significance of anticardiolipin antibodies in pregnancies complicated by parvovirus B19 infection ????Prenat Diagn http://www.kidney.de/pget.php?&tw=1&pmid=8750289 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=8750289 #FOAvip English Wikipedia <ref>{{Cite pmid|8750289}}</ref> Prevalence and clinical significance of anticardiolipin antibodies in pregnancies complicated by parvovirus B19 infection #MMPMID8750289 Gratacos E; Torres PJ; Vidal J; Font J; Antolin E; Cararach V; Fortuny A Prenat Diagn 1995[Dec]; 15 (12): 1109-13 PMID8750289show ga Anticardiolipin antibodies were measured in 60 pregnant women with acute parvovirus B19 infection. Test results for eight (13.3 per cent) women were positive for anticardiolipin antibody. Six of these eight women became negative later, yielding a prevalence of anticardiolipin antibodies of 3.3 per cent (2/60) 6 months after acute parvovirus B19 infection. Anticardiolipin antibody positivity was not associated with an increased risk of abortion, fetal death, or maternal complications. This study suggests that there is an elevated frequency of anticardiolipin antibodies in pregnant women with acute parvovirus B19, probably representing an epiphenomenon. However, this is not associated with an adverse maternal or perinatal outcome. |*Parvovirus B19, Human[MESH] |Antibodies, Anticardiolipin/*blood[MESH] |Erythema Infectiosum/*immunology[MESH] |Female[MESH] |Humans[MESH] |Immunoglobulin G/blood[MESH] |Immunoglobulin M/blood[MESH] |Pregnancy[MESH] |Pregnancy Complications, Infectious/*immunology[MESH]Prevalence and clinical significance of anticardiolipin antibodies in (epmc).pdf DeepDyve Pubget Overpricing